Cornell experts from Ithaca and New York City gathered June 26-27 at the College of Veterinary Medicine for the Immunology in Health and Disease Symposium.
The Atkinson Center for a Sustainable Future’s Academic Venture Fund has awarded $1.5 million to a range of projects that will provide sustainable solutions around the world, from the Finger Lakes to the Pamir Mountains in Central Asia.
Thirty-three researchers from across the globe visited the Bronfenbrenner Center for Translational Research last month to learn how to conduct research through community partnerships that will inform real-world practices and decisions.
Growing miniature tumors from a patient’s cells in the laboratory may help scientists personalize treatments for those with a rare form of prostate cancer, according a study by Weill Cornell Medicine and NewYork-Presbyterian scientists.
A very low carbohydrate, high-fat diet called the ketogenic diet may improve the effectiveness of an emerging class of cancer drugs, according to a new study.
Researchers at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center propose a simpler, safer procedure for treating a certain type of early-stage kidney cancer in older adults.
Christopher Wildeman, a leading scholar on mass incarceration and child maltreatment, will become director of the Bronfenbrenner Center for Translational Research as of July 1.
A year into Cornell’s Academic Integration Initiative, Gary Koretzky ’78 is relocating to Ithaca and taking on a new title to continue leading efforts to better promote, build and enhance collaborative research efforts across Cornell's campuses.
